FR2336930B1 - - Google Patents

Info

Publication number
FR2336930B1
FR2336930B1 FR7630125A FR7630125A FR2336930B1 FR 2336930 B1 FR2336930 B1 FR 2336930B1 FR 7630125 A FR7630125 A FR 7630125A FR 7630125 A FR7630125 A FR 7630125A FR 2336930 B1 FR2336930 B1 FR 2336930B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7630125A
Other languages
French (fr)
Other versions
FR2336930A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of FR2336930A1 publication Critical patent/FR2336930A1/fr
Application granted granted Critical
Publication of FR2336930B1 publication Critical patent/FR2336930B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/92—Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7630125A 1975-12-30 1976-10-06 Procede de production de derives de triazolylbenzophenones et nouveaux produits ainsi obtenus, notamment utiles comme produits sedatifs et hypnotiques Granted FR2336930A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (2)

Publication Number Publication Date
FR2336930A1 FR2336930A1 (fr) 1977-07-29
FR2336930B1 true FR2336930B1 (ja) 1978-12-22

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7630125A Granted FR2336930A1 (fr) 1975-12-30 1976-10-06 Procede de production de derives de triazolylbenzophenones et nouveaux produits ainsi obtenus, notamment utiles comme produits sedatifs et hypnotiques

Country Status (19)

Country Link
JP (1) JPS5283469A (ja)
AR (2) AR218613A1 (ja)
AT (1) AT350052B (ja)
AU (1) AU498113B2 (ja)
BE (1) BE846410A (ja)
CA (1) CA1126274A (ja)
CH (1) CH623315A5 (ja)
DE (1) DE2641164A1 (ja)
DK (1) DK393576A (ja)
ES (3) ES451896A1 (ja)
FR (1) FR2336930A1 (ja)
GB (1) GB1531980A (ja)
HU (1) HU172539B (ja)
IE (1) IE43841B1 (ja)
IL (1) IL50664A (ja)
NL (1) NL7610799A (ja)
NZ (1) NZ181958A (ja)
SE (1) SE7609813L (ja)
ZA (1) ZA765851B (ja)

Also Published As

Publication number Publication date
DK393576A (da) 1977-07-01
AR220519A1 (es) 1980-11-14
GB1531980A (en) 1978-11-15
HU172539B (hu) 1978-09-28
CA1126274A (en) 1982-06-22
DE2641164A1 (de) 1977-07-14
NZ181958A (en) 1979-03-28
IE43841L (en) 1977-06-30
AT350052B (de) 1979-05-10
BE846410A (fr) 1977-01-17
CH623315A5 (en) 1981-05-29
AR218613A1 (es) 1980-06-30
ZA765851B (en) 1977-09-28
NL7610799A (nl) 1977-07-04
FR2336930A1 (fr) 1977-07-29
SE7609813L (sv) 1977-07-01
AU1749876A (en) 1978-03-16
AU498113B2 (en) 1979-02-08
IL50664A (en) 1983-09-30
IL50664A0 (en) 1976-12-31
IE43841B1 (en) 1981-06-03
ES451896A1 (es) 1978-01-16
JPS5283469A (en) 1977-07-12
ES462243A1 (es) 1978-06-01
ES462244A1 (es) 1978-06-01
ATA684276A (de) 1978-10-15

Similar Documents

Publication Publication Date Title
AU495923B2 (ja)
CH604969A5 (ja)
CH596506A5 (ja)
BG21442A1 (ja)
BG21446A1 (ja)
BG21895A1 (ja)
BG22196A1 (ja)
BG23540A3 (ja)
BG26526A3 (ja)
CH574340A5 (ja)
CH579725A5 (ja)
CH583651A5 (ja)
CH585472A5 (ja)
CH585655A5 (ja)
CH586052A5 (ja)
CH586576A5 (ja)
CH586682A5 (ja)
CH592012A5 (ja)
CH592426A5 (ja)
CH594296A5 (ja)
CH594314A5 (ja)
CH594759A5 (ja)
CH594811A5 (ja)
CH595421A5 (ja)
CH595486A5 (ja)

Legal Events

Date Code Title Description
ST Notification of lapse